INS and metabolic dysfunction-associated steatotic liver disease: The pharmacological treatment options for NAFLD include insulin sensitizers (metformin, rosiglitazone, and semaglutide), lipid-lowering drugs (clofibrate, gemfibrozil, and atorvastatin), angiotensin receptor blockers (telmisartan and candesartan), pentoxifylline, ursodeoxycholic acid, and antioxidants, but also herbal medicines [9].